Putney Financial Group’s Transmedics TMDX Stock Holding History

Putney Financial Group’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$161K	Buy	+1,930	New	+$159K	0.13%	88

Other funds holding TMDX

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return

Zevenbergen Capital Investments Edmonds, Washington $4.37B AUM 52.9% 1-Year Est. Return

Putney Financial Group's TMDX Position: Q3 2026 in Review

Putney Financial Group opened a new position in Transmedics (TMDX) in Q3 2026: 1,930 shares worth $161K. The stake represents 0.13% of the portfolio and ranks #88 among its holdings.

217 funds tracked by Wall St. Rank hold TMDX as of Q3 2026.

Putney Financial Group held 1,930 shares of Transmedics worth $161K as of Q3 2026.
Transmedics was a new Putney Financial Group position in Q3 2026.
Transmedics made up 0.13% of Putney Financial Group's portfolio in Q3 2026, its #88 holding.
217 funds tracked by Wall St. Rank held Transmedics as of Q3 2026.

Based on Putney Financial Group's 13F filing for Q3 2026, filed 30 Oct 2026.